Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Figure 1 The flowchart illustrating the design of this research.
MPSS: Methylprednisolone sodium succinate; RSSHL: Refractory sudden sensorineural hearing loss; DM: Diabetes mellitus.
- Citation: Li D, Qiao F, Dai J, Xu M, Gong HY, Yang HM, Li JC, Huai D. Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients. World J Diabetes 2025; 16(5): 99576
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/99576.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.99576